Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

INTRODUCTION: Non-clear cell renal cell carcinoma (nccRCC) and sarcomatoid renal cell carcinoma (sRCC) are underrepresented in clinical trials. Treatment approaches are frequently extrapolated from data of clear cell renal cell carcinoma, in which pazopanib is non-inferior to sunitinib. We aim to co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Bonadioa, Renata Colombo, Velho, Pedro Isaacsson, Marta, Guilherme Nader, Nardo, Mirella, Souza, Manoel Carlos LA, Muniz, David QB, Bezerra, Regis OF, Bispo, Raisa KA, Faraj, Sheila F, Bastos, Diogo A, Dzik, Carlos
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946421/
https://ncbi.nlm.nih.gov/pubmed/31921344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2019.973
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados